The Year in Medicine
While waiting for my MRI, I picked up the end of year issue of Time magazine and was SUPRISED to read the below excerpt...
"Breast Cancer When the authors of a large international study reported that Herceptin, a powerful drug for treating advanced cases of so-called HER2-positive breast cancers, could also dramatically reduce--by 46%--recurrence of early-stage HER2 cancers, they triggered impassioned requests for the drug by patients and fierce debate among doctors. At issue was whether the trial, which had reported interim--not final--results, was reliable enough to persuade doctors to change their treatment practices. Most physicians have decided to wait for the trial to be completed in 2008 before making any decisions."
I guess I should be THANKFUL that I have such an aggressive oncologist.
Rhonda Hoffman
|